Literature DB >> 18001209

Putative cancer chemopreventive agents of dietary origin-how safe are they?

Richard D Verschoyle1, William P Steward, Andreas J Gescher.   

Abstract

As cancer chemopreventive agents are intended for use by healthy individuals as prophylactics to prevent or retard the development of cancer, they must be amenable to ingestion over prolonged periods without toxicity. Therefore, putative chemopreventive agents need to undergo stringent testing to ensure their safety with regard to chronic exposure in humans. The diet is thought to be a source of chemopreventive agents, and dietary compounds are generally considered to be of low hazard, albeit this notion has not often been put to the test. Here the safety information available for 5 dietary putative chemopreventive compounds, indole-3-carbinol (I3C), curcumin, quercetin, epigallocatechin gallate (EGCG), and capsaicin is reviewed. For these agents, normal dietary intake, doses used in clinical trials, efficacious doses in rodents, and where available, toxic doses are compared. For curcumin, quercetin and capsaicin, toxicological data is only available from studies in rodents. Information on long-term effects in animals beyond 28 or 90 days is lacking for EGCG. Capsaicin and quercetin are suspected carcinogens. I3C and quercetin can modulate the absorption of other drugs given concomitantly. Without further investigation of their toxicology, it is difficult to recommend any of these agents for long-term use in the healthy population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18001209     DOI: 10.1080/01635580701458186

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  11 in total

Review 1.  Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing.

Authors:  Muobarak Jaber Tuorkey
Journal:  Interv Med Appl Sci       Date:  2014-12-22

2.  Measurement of spices and seasonings in India: opportunities for cancer epidemiology and prevention.

Authors:  Leah M Ferrucci; Carrie R Daniel; Kavita Kapur; Puneet Chadha; Hemali Shetty; Barry I Graubard; Preethi S George; Whitney Osborne; Susan Yurgalevitch; Niveditha Devasenapathy; Nilanjan Chatterjee; Dorairaj Prabhakaran; Prakash C Gupta; Aleyamma Mathew; Rashmi Sinha
Journal:  Asian Pac J Cancer Prev       Date:  2010

3.  p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.

Authors:  Srirupa Roy; Mallikarjuna Gu; Kumaraguruparan Ramasamy; Rana P Singh; Chapla Agarwal; Sunitha Siriwardana; Robert A Sclafani; Rajesh Agarwal
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

4.  In silico analysis and molecular docking studies of potential angiotensin-converting enzyme inhibitor using quercetin glycosides.

Authors:  Syed Aun Muhammad; Nighat Fatima
Journal:  Pharmacogn Mag       Date:  2015-05       Impact factor: 1.085

5.  Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia.

Authors:  Balaji Ramachandran; Subramani Jayavelu; Kanchan Murhekar; Thangarajan Rajkumar
Journal:  Toxicol Rep       Date:  2016-03-05

6.  Molecular docking studies of quercetin and its analogues against human inducible nitric oxide synthase.

Authors:  Salam Pradeep Singh; Bolin Kumar Konwar
Journal:  Springerplus       Date:  2012-12-17

7.  Involvement of salicylic acid on antioxidant and anticancer properties, anthocyanin production and chalcone synthase activity in ginger (Zingiber officinale Roscoe) varieties.

Authors:  Ali Ghasemzadeh; Hawa Z E Jaafar; Ehsan Karimi
Journal:  Int J Mol Sci       Date:  2012-11-13       Impact factor: 5.923

8.  Use of natural products as chemical library for drug discovery and network pharmacology.

Authors:  Jiangyong Gu; Yuanshen Gui; Lirong Chen; Gu Yuan; Hui-Zhe Lu; Xiaojie Xu
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

9.  Botanical compounds: effects on major eye diseases.

Authors:  Tuan-Phat Huynh; Shivani N Mann; Nawajes A Mandal
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-17       Impact factor: 2.629

Review 10.  Antibacterial Action of Curcumin against Staphylococcus aureus: A Brief Review.

Authors:  Sin-Yeang Teow; Kitson Liew; Syed A Ali; Alan Soo-Beng Khoo; Suat-Cheng Peh
Journal:  J Trop Med       Date:  2016-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.